Hims & Hers Health, Inc.: Please contact the Portnoy Law Firm to recover your losses; August 25, 2025 Deadline to file Lead Plaintiff Motion

Core Viewpoint - Hims & Hers Health, Inc. is facing a class action lawsuit due to allegations of deceptive practices related to the promotion and sale of illegitimate versions of Novo Nordisk's weight loss drug, Wegovy® [3][4][5] Group 1: Company Overview - Hims & Hers Health is a telehealth company that offers prescription and over-the-counter medications, as well as personal care products [3] Group 2: Legal Allegations - The class action lawsuit claims that during the class period from April 29, 2025, to June 23, 2025, the company made false or misleading statements and failed to disclose material facts [4] - Allegations include that Hims & Hers was involved in the deceptive promotion and sale of illegitimate versions of Wegovy®, which jeopardized patient safety [4] - The lawsuit also suggests that there was a significant risk of Novo Nordisk terminating its collaboration with Hims & Hers due to these practices [4] Group 3: Impact of the Lawsuit - On June 23, 2025, Novo Nordisk announced the termination of its partnership with Hims & Hers, citing concerns over deceptive practices that endangered patient safety [5] - Following this announcement, shares of Hims & Hers experienced a decline of over 34% [5]